China Epilepsy Surgery Market

ID: MRFR/HC/51356-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026
China Epilepsy Surgery Market Research Report By Procedure Type (Respective Surgery, Laser Interstitial Thermal Therapy (LITT)) and By End User (Hospitals & Clinics, Specialty Centers) - Growth & Industry Forecast 2025 To 2035
China Epilepsy Surgery Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.35%
2024 Market Size$ 74.4 Million
2025 Market Size$ 78.78 Million
2035 Market Size$ 132 Million
Key Players
Medtronic
Johnson & Johnson
Stryker
Boston Scientific
Abbott Laboratories
NeuroPace
Trends
  • Technological Advancements in Surgical Techniques
  • Government Initiatives to Enhance Healthcare Access
  • Growing Awareness and Education on Epilepsy
Opportunities
  • Rising Incidence of Epilepsy
  • Advancements in Surgical Technologies
  • Government Support and Policy Initiatives
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Surgical Procedure Type (USD Million)
      1. 4.1.1 Resective Surgery
      2. 4.1.2 Functional Surgery
      3. 4.1.3 Lesionectomy
      4. 4.1.4 Hemispherectomy
    2. 4.2 Healthcare, BY Indication (USD Million)
      1. 4.2.1 Focal Epilepsy
      2. 4.2.2 Generalized Epilepsy
      3. 4.2.3 Refractory Epilepsy
      4. 4.2.4 Non-epileptic Seizures
    3. 4.3 Healthcare, BY Patient Age Group (USD Million)
      1. 4.3.1 Pediatric
      2. 4.3.2 Adolescent
      3. 4.3.3 Adult
      4. 4.3.4 Geriatric
    4. 4.4 Healthcare, BY Technology (USD Million)
      1. 4.4.1 Neurostimulation Devices
      2. 4.4.2 Surgical Navigation Systems
      3. 4.4.3 Robotic Surgery Systems
      4. 4.4.4 Imaging Techniques
    5. 4.5 Healthcare, BY Healthcare Setting (USD Million)
      1. 4.5.1 Hospitals
      2. 4.5.2 Specialized Epilepsy Centers
      3. 4.5.3 Outpatient Clinics
      4. 4.5.4 Research Institutions
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (CN)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Johnson & Johnson (CN)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Stryker (CN)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Boston Scientific (CN)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Abbott Laboratories (CN)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 NeuroPace (CN)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 LivaNova (CN)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Natus Medical (CN)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Integra LifeSciences (CN)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 CHINA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE
    3. 6.3 CHINA MARKET ANALYSIS BY INDICATION
    4. 6.4 CHINA MARKET ANALYSIS BY PATIENT AGE GROUP
    5. 6.5 CHINA MARKET ANALYSIS BY TECHNOLOGY
    6. 6.6 CHINA MARKET ANALYSIS BY HEALTHCARE SETTING
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 TO 2035 (USD Million)
    15. 6.15 HEALTHCARE, BY INDICATION, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Million)
    17. 6.17 HEALTHCARE, BY PATIENT AGE GROUP, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY PATIENT AGE GROUP, 2024 TO 2035 (USD Million)
    19. 6.19 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
    21. 6.21 HEALTHCARE, BY HEALTHCARE SETTING, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY HEALTHCARE SETTING, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SURGICAL PROCEDURE TYPE, 2026-2035 (USD Million)
      2. 7.2.2 BY INDICATION, 2026-2035 (USD Million)
      3. 7.2.3 BY PATIENT AGE GROUP, 2026-2035 (USD Million)
      4. 7.2.4 BY TECHNOLOGY, 2026-2035 (USD Million)
      5. 7.2.5 BY HEALTHCARE SETTING, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

China Epilepsy Surgery Market Segmentation

China Epilepsy Surgery Market By Surgical Procedure Type (USD Million, 2026-2035)

  • Resective Surgery
  • Functional Surgery
  • Lesionectomy
  • Hemispherectomy

China Epilepsy Surgery Market By Indication (USD Million, 2026-2035)

  • Focal Epilepsy
  • Generalized Epilepsy
  • Refractory Epilepsy
  • Non-epileptic Seizures

China Epilepsy Surgery Market By Patient Age Group (USD Million, 2026-2035)

  • Pediatric
  • Adolescent
  • Adult
  • Geriatric

China Epilepsy Surgery Market By China Epilepsy Surgery Market (USD Million, 2026-2035)

  • Neurostimulation Devices
  • Surgical Navigation Systems
  • Robotic Surgery Systems
  • Imaging Techniques

China Epilepsy Surgery Market By China Epilepsy Surgery Market Setting (USD Million, 2026-2035)

  • Hospitals
  • Specialized Epilepsy Centers
  • Outpatient Clinics
  • Research Institutions

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.